Login / Signup
Bishan Su
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Cancer Therapy
Open Label
Mesenchymal Stem Cells
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Hao Fu
,
Jinxiong Huang
,
Tianzhi Zhao
,
Hongjian Wang
,
Yuhang Chen
,
Weizhi Xu
,
Yizhen Pang
,
Wei Guo
,
Long Sun
,
Hua Wu
,
Pengfei Xu
,
Bishan Su
,
Jingjing Zhang
,
Xiaoyuan Shawn Chen
,
Haojun Chen
Fibroblast Activation Protein-Targeted Radioligand Therapy with 177Lu-EB-FAPI for Metastatic Radioiodine Refractory Thyroid Cancer: First-in-Human, Dose-Escalation Study.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)